IJ Pharmaceutical Research
Crossref
1. CDK9 inhibitors in multiple myeloma: a review of progress and perspectives
- Jędrzej Borowczak
- Krzysztof Szczerbowski
- Navid Ahmadi
- Łukasz Szylberg
2. Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities
- Mitra Zabihi
- Ramin Lotfi
- Amir-Mohammad Yousefi
- Davood Bashash
3. Inhibitor of Multi-cyclin-dependent Kinases (AT7519) Reduced Survival of U937 Leukemic Cells and Enhanced Anti-leukemic Effect of Vincristine: A Highlight to CDK Inhibition Efficacy in Acute Leukemia
- Fateme Moradi Moraddahande
- Mona Shameli Houjghan
- Amir-Mohammad Yousefi
- Ava Safaroghli-Azar
- Atieh Pourbagheri-Sigaroodi
- Davood Bashash